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Abstract
Background: Earlier detection of  oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders 
(OPMD) is essential for dental professionals to improve patient survival rates. The aim of this systematic review 
is to to evaluate the effectiveness of devices that utilise the principles of chemiluminescence and tissue autofluo-
rescence as adjuncts in the detection of OSCC and OPMD.
Material and Methods: The electronic retrieval systems and databases searched for relevant articles were PubMed 
[MEDLINE] and Science direct. The search was for limited articles published in English or with an English ab-
stract and articles published during the period from January 2005 to April 2014. Clinical trials utilized ViziLite, 
Microlux TM/DL and Visual Enhanced Light scope (VELscope) for early detection of OPMD and OSCC.
Results: Twenty primary studies published satisfied our criteria for selection - 10 utilised chemiluminescence and 
10 tissue autofluorescence. Senstivity of Vizilite for detecting OSCC nad OPMD ranged from 77.1 % to 100% and 
specificity was low that  ranged from 0% to 27.8%.Most  have shown that chemiluminescence increases the bright-
ness and margins of oral mucosal white lesions and thus assist in identification of mucosal lesions not considered 
under Conventional visual examination. However, it preferentially detects leukoplakia and may fail to spot red 
patches. Clinical trials demonstrated that sensitivity of VELscope in detecting malignancy and OPMD ranged 
from 22 % to 100 % and specificity ranged from 16 % to 100%. Most studies concluded that VELscope can help 
the experienced clinician to find oral precursor malignant lesions. But it couldnot differentiate between dysplasia 
and benign inflammatory conditions.
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Conclusions: Both devices are simple, non-invasive test of the oral mucosa but are suited for clinicians with sufficient 
experience and training. More clinical trials in future should be conducted to establish optical imaging as an effica-
cious adjunct tool in early diagnosis of OSCC and OPMD.
Key words: Oral cancer, early diagnosis, potentially malignant disorders, chemiluminescence, tissue autofluores-
cence, VELscope, ViziLite plus.
Introduction
Oral malignancies are one of the most common cancers 
around the world and ranks sixth to eighth among can-
cers in various studies. These cancers are major eco-
nomic and clinical burden for the health care around the 
world (1). In India, oral cancer represents a major health 
problem accounting for upto 40 % of all cancers, and is 
most common cancer in males and third most common 
cancer in females. It often arises from Oral potential 
malignant disorders (OPMDs) such as erythroplakia, 
leukoplakia and oral Lichen planus (2). Leukoplakia is 
the most common OPMD and its worldwide prevalence 
is approximately 2.6% (3).
Risk factors for oral cancer are well established and 
include tobacco and alcohol use (4). Despite the estab-
lished risk factors and advances in treatment, the 5-year 
survival for oral squamous cell carcinoma (OSCC) as-
sociated with tobacco and alcohol use has remained 
consistently poor for the last forty years (5). Prognosis 
is further complicated by the high rate of second pri-
mary tumours in these patients, which is thought to be 
the result of ‘field cancerisation’ in the upper aerodiges-
tive tract (6).
Early detection of neoplastic changes in the oral cavi-
ty is the best method to improve patient survival rates 
(7). The current method of oral cancer diagnosis, visual 
examination of the oral cavity, relies heavily on clini-
cal expertise in recognizing early neoplastic changes. 
However, discerning premalignant and early malignant 
lesions from common benign inflammatory conditions 
by visual examination is difficult, even for experienced 
practitioners (8). Many techniques to date have been 
reviewed so far e.g. vital staining procedure (Toulidi-
ne  Blue and Lugols iodine), Brush Biopsy (Oral CDx 
Brush),micronuclei anlaysis, DNA ploidy but have cer-
tain limitations (2). Light-based techniques, including 
chemiluminescence and autofluorescent imaging, work 
on the assumption that neoplastic and pre-neoplastic tis-
sues that have undergone abnormal metabolic or struc-
tural changes have different absorbance and reflectan-
ce properties when exposed to specific wavelengths of 
light. In the last decade, light-based technology has been 
adapted and marketed for use in the oral cavity (chemilu-
minescence: ViziLite, ViziLite Plus, MicroLuxTM/DL; 
autofluorescence: VELscope (Visual Enhanced Light 
scope) (9). The objective of this systematic review is to 
evaluate the literature investigating the effectiveness of 
chemiluminescence and autofluorescent imaging devi-
ces as aids in the detection of OSCC and OPMDs and 
encouraging dental professionals to use these light ba-
sed detection devices in clinical practice.
Material and Methods
A systematic review of the scientific literature was 
done in preparation of manuscript. The electronic re-
trieval systems and databases searched for relevant ar-
ticles were PUBMED [MEDLINE] and SCIENCE DI-
RECT. Database of indexed journals were searched for 
keywords such as Oral cancer, early diagnosis, poten-
tially malignant disorders, chemiluminescence; tissue 
autofluorescence, VELscope; ViziLite Plus. The inclu-
sion criteria were the use of light based techniques for 
early diagnosis of OSCC or OPMD, publications report-
ing primary studies and publications written in English. 
The exclusion criteria were case reports, reviews and 
studies in other languages.
Results
For the use of chemiluminescence aids (ViziLite, 
ViziLite plus and MicroluxTM DL) in the detection of 
OPMD and OSCC ten studies satisfied our inclusion 
and exclusion criteria. These studies were conducted 
in clinics of countries such as Malaysia (10), Australia 
(11,12), USA (13), India (14-16) and UK (17). Most stud-
ies used ViziLite to detect OPMD and OSCC but one 
study used Microlux TM/DL (12). Table 1 and 1 contin-
ue, illustrates the clinical trials conducted in literature 
establishing the role of chemiluminescence in detection 
of OPMD and OSCC.
Most studies were cross sectional studies and several 
parameters were considered for correct evaluation. The 
sensitivity of a test, is the proportion of people who test 
positive for a specific disease among a group of people 
who have the disease. Specificity is the proportion of peo-
ple who test negative for a specific disease among a group 
of people who do not have the disease. False positive is an 
erroneously positive test or screening result. False nega-
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Author 
(year) Study design 
Sample, Selection 
criteria Intervention 
Outcome: 
senstivity 
Outcome: 
specificity 
Summary of findings, 
Conclusion 
Ram S et al. 
2005 ( 10) 
Cross-
sectional 
study 
46 patients (OSCC 
14,26 OPMD, 6 
benign) 
 
Selection criteria 
Oral mucosal 
white lesion 
Chemiluminescence 
as an diagnostic aid 
for detection of oral 
cancer and 
potentially 
malignant epithelial 
lesions 
100% 14.2% Conclusion: 
chemiluminescence is a more 
reliable diagnostic tool than 
tolonium chloride in the 
detection of oral cancer and 
PMELs, and for follow-up of 
patients treated for the same. 
Farah and Mc 
Cullough. 2007 
(11) 
Cross-
sectional 
study 
55 patients(1 
OSCC,9dysplasias, 
45 benign lesions) 
 
Selection criteria: 
Oral mucosal 
white lesion 
Efficacy of acetic 
acid wash and 
chemiluminescent 
illumination 
(ViziLite 
Trademark) in the 
visualization of oral 
mucosal white 
lesions 
OSCC:100
% 
Dysplasa:1
00% 
0% OSCC 
All cases were viziLite 
positive. No false negatives. 
Benign 
All benign lesion were 
ViziLite positive.This 
represented 45 false positive 
screens 
 
Conclusion 
The device doesnot help in 
identification of malignant 
and potentially malignant 
lesions 
 
Epstein et al. 
2008 (13) 
Cross 
sectional 
study 
84 patients(9 
OSCC,4 CIS, 41 
dysplasia,43 
benign) 
 
Selection criteria: 
Oral mucosal 
white lesion 
Previous history of 
OSCC or high risk 
patients 
Analysis of oral 
lesion biopsies 
identified and 
evaluated by visual 
examination, 
chemiluminescence 
and toulidine blue 
Not 
reported 
Not reported OSCC/OPMD 
All were ViziLite positive 
Benign 
All lesions without dysplasia 
were ViziLite positive 
representing 43 percent false 
positive screens. 
TBlue 
Identified 1/3 benign 
lesions,58%mild to moderate 
lesions and 100 % of Severe 
pathologies 
Conclusion 
TBlue reduced the number of 
false positive screens 
 
McIntosh et al. 
2009 (12) 
Cross  
sectional 
study 
50 patients( 2 
OSCC, 7 
dysplasia,41 
benign) 
 
Selection criteria: 
Oral mucosal 
white lesion 
Assessment of 
diffused light 
illumination and 
acetic acid rinse 
(Microlux/DLTM) in 
the visualization of 
oral mucosal lesions 
Dysplasia/
OSCC: 
77.8% 
70.7% OSCC/OPMD 
Microlux /DL showed no 
positive result in  2 dysplastic 
lesions. 
Benign  
12 benign lesions elicited 
ViziLite positive responses 
 
Conclusion: 
Unable to discriminate 
malignancy,OPMD, benign 
keratosis, inflammatory 
conditions 
Mehrotra et al. 
2010 (14) 
Cross 
sectional 
study 
102 patients( 1 
OSCC, 3 
dysplasia, 98 
benign) 
 
Selection criteria: 
Oral mucosal 
white lesion 
Evaluation of 
chemiluminescence 
and auto 
fluorescence in the 
detection of 
clinically innocuous 
precancerous and 
cancerous oral 
lesions 
OSCC :0% 
Dysplasia:0
% 
75.5% OSCC/OPMD 
The device failed to detect all 
3 cases of dysplasia and 1 
case of OSCC representing 4 
false negative screens 
Benign: 
24 of74 benign lesions elicited 
ViziLite positive response 
 
Conclusion: 
ViziLite plus system offers no 
benefit in detecting OSCC and 
OPMD 
Table 1. Summarizes the clinical trials to evaluate the efficacy of chemiluminescence in detection of oral cancer and oral po-
tentially malignant disorders.
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tive is an erroneously negative test or screening result.
Senstivity of Vizilite for detecting OSCC and OPMD 
ranged from  7.1 % to 100% and  specificity was low that 
ranged from 0% to 27.8%. In a study by Ram et al. the 
sensitivity of vizilite was 100% and specificity was low 
14.2 % (10). Ujaoney et al. found toulidine was better 
suited than chemiluminescence for detecting high risk 
patients (15). McIntosh et al. used Microlux DL in his 
study with sensitivity of 77.8 % and specificity of 70.7%. 
in detecting dysplasia and OSCC but Microlux TM/DL 
couldnot discriminate between malignancy, OPMD, be-
nign keratosis and inflammatory conditions (12).
For the use of VELscope in detection of OSCC and 
OPMD ten studies in literature satisfied our inclusion 
and exclusion criteria. These studies were mainly cross-
sectional and were carried out in clinics of countries 
such as UK (18), Canada (19), Germany (20-22), Italy 
(23), USA (24,25),  Poland (26) and India (14). Clini-
cal trials demonstrated that sensitivity of VELscope in 
detecting malignancy and OPMD ranged from 22 % to 
100 % and specificity ranged from 16 % to 100%.Most 
studies concluded that VELscope can help the experi-
enced clinician to find oral precursor malignant lesions 
(20,22,25). Table 2 and 2 continue, summarizes clini-
 
Awan et al. 
2011 (17) 
Cross 
sectional 
study 
126 patients 
OPMD/benign (61 
leukoplakia,9eryth
roplakia, 32 lichen 
planus/lichenoid 
reaction,9 chronic 
hyperplastic 
candidiasis,2 oral 
submucous 
fibrosis) 
44 dysplasia, 56 
benign 
 
Selection criteria: 
Patients with 
white, red , mixed 
red and white 
Patches. 
Utility of 
chemiluminescence 
(ViziLite) in the 
detection of orally 
potential malignant 
disorders and 
benign keratoses 
Dysplasia 
77.3% 
Leuko/eryh
troplakia: 
77.1% 
Dysplasia: 
27.8% 
Leuko/erythr
oplakia: 
26.8% 
OPMD/DYSPLASIA 
80.3% of leukoplakia lesions 
elicited ViziLite positive 
result.Fifty percent of 
erythroplakia lesions elicited 
vizilite positive result 
Benign 
52 benign positive ViziLite 
response 
 
Conclusion: 
The device has low specificity 
for dysplasia and is poor at 
detecting some red lesiuons 
Ujaoney et al. 
2012 (15) 
Cross 
sectional 
study 
50 patients 
(OPMD/benign) 
 
Selection criteria: 
Patients with at 
least one 
precancerous 
lesion 
Evaluation of 
chemiluminescsnce, 
toulididine blue and 
histopathology for 
detection of high 
risk oral 
precancerous 
lesions 
Vizilite 
:100% 
TBlue:59% 
Vizilite:1% 
Tblue:79% 
Conclusion: 
Toluidine blue retention test 
may be better suited than 
chemiluminescence to detect 
high-risk oral precancerous 
lesions in a high-prevalence 
and low-resource setting like 
India. 
Rajmohan  et al. 
2012 (16) 
Cross 
sectional 
study 
30 patients (10 
OSCC,9 
dysplasia,1 
benign,10 normal) 
 
Selection criteria: 
Group I: Patients 
with normal 
appearing mucosa 
(10) 
Group II: 
Clinically 
diagnosed 
precancer (10) 
Group III: 
clinically 
suggestive of 
cancer (10) 
Assessment of oral 
mucosa in normal, 
precancer and 
cancer using 
chemiluminescent 
illumination,toulidin
e blue supravital 
staining and oral 
exfoliative cytology 
Dysplasia: 
77.8% 
OSCC:90% 
Not reported OSCC/dysplasia 
Negative results in three 
erosive lesions . 
 
Conclusion 
Vizilite was sensitive for 
precancerous and cancerous 
lesions with keratotic or red 
white characteristics 
Table 1 Continue. Summarizes the clinical trials to evaluate the efficacy of chemiluminescence in detection of oral cancer and oral po-
tentially malignant disorders.
OPMD; Oral Potentially Malignant Disorders, OSCC; Oral Squamous Cell Carcinoma.
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Author 
(year) Study design 
Sample, Selection 
criteria Intervention 
Outcome: 
senstivity 
Outcome: 
specificity 
Summary of findings, 
Conclusion 
Sharwani A et al.  
2006 (18) 
Cross sectional 
study 
79 patients 
Selection criteria: 
Clinically suspicious oral 
leukoplakia 
Fluorescence 
spectroscopy 
combined with  
5-aminolevulinic  
acid induced 
protophyrin IX 
fluorescence in 
detecting oral 
premalignancy 
83-90% 79-89% Increase in red to green 
fluorescence in dysplastic lesion 
Conclusion: 
Fluorescence spectroscopy 
combined with 5 aminolevulinic 
acid induced protophyrin IX 
valuable tool in diagnosis of oral 
premalignancy 
Lane et al.  
 2006 (19) 
Cross sectional 
study 
44 patients ( 11 severe 
dysplasia,33 OSCC, 6 
normal) 
Selection criteria 
Oral leukoplakia patients 
Direct visualization 
of oral cavity tissue 
fluorescence 
98% 100% Conclusion: 
Device could be used as an 
adjunct to conventional white 
light screening to increase the 
sensitivity of the white light 
screen alone 
Mehrotra et al.  
2010 (14) 
Cross sectional 
study 
156 patients( 1 OSCC,11 
dysplsia,144 benign 
lesions ) 
Selection criteria 
Oral mucosal white 
lesions 
Evaluation of 
chemiluminescence 
and auto fluorescence 
in the detection of 
clinically innocuous 
precancerous and 
cancerous oral 
lesions 
50% 
OSCC:100% 
Dysplasia:45% 
38.9% OSCC/Dysplasia 
6 dysplastic lesions did not show 
FVL, representing 6 false negative 
screens 
Benign lesions 
FVL in 88 benign lesions, 
representing false positive screens 
 
Conclusion: 
VELscope doesnot add any 
benefits to a conventional 
screening examination with a 
standard overhead light 
Koch et al. 2011 
(21) 
Prospective 
blinded clinical 
trial 
78 patients(30 OSCC,3 
dysplasia, 45 benign) 
Selection criteria 
OSCC patients or 
suspicious epithelial 
lesion 
 
 
Effectiveness of 
autofluorescence to 
identify suspicious 
oral lesions 
OSCC:93% 16% OSCC/Dysplasia 
FVL, although highly sensitive 
,not very specific for OSCC and 
dysplasia 
Red color autofluorescence in a 
lesion was highly specificto 
dysplasia/OSCC (98) but had a 
low sensitivity (22%) 
 
Hyperkeratosis and erythema 
VELscope was less able to detect 
OSCC with hyperkeraosis.OSCC 
with erythema was more likely to 
elicit FVL (92 % sensitive) 
 
Conclusion: 
Autofluroscence unable to 
differentiate between benign and 
malignant lesions.Lesion with red 
color autofluorescence should be 
biopsed 
Paderni et al. 2011 
(23) 
Cross sectional 
study 
175 patients(118 
benign,15 mild 
dysplasia,14 
moderate/severe 
dysplasia,28 OSCC) 
Selection criteria: 
Patients with atleast one 
clinical oral lesion 
 
Direct visualization 
of oral cavity tissue 
fluorescence as novel 
aid for early oral 
cancer diagnosis and 
potentially malignant 
disorders monitioring 
OSCC: 96.4% 
Dysplasia:71% 
Not reported Conclusion: 
Device dosesnot reduce 
histopathology procedure 
Marzouki et al. 
2012 (24) 
Prospective single 
blind study 
85 patients (biopsy 
confirmed 33 
OSCC/OPMD) 
Selection criteria: 
History of smoking, 
alcohol use or previous 
head and neck cancer 
Use of fluorescent 
light in detecting 
malignant and 
premalignant lesions 
in oral cavity 
Dysplasia:92% Dysplasia: 
77% 
VELscope showed FVL in 12 
OPMD/dysplasias, 5 which were 
not noted on conventional visual 
inspection 
VELscope failed to show FVL in 
1 OPMD detected on 
conventional visual inspection 
Conclusion: 
VELscope useful tool in high risk 
patient 
Table 2. Summarizes clinical trials to evaluate the efficacy of autofluorescence imaging ( VELscope) in detecting oral cancer and oral 
potentially malignant disorders.
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cal trials conducted in literature to test the efficacy of 
VELscope in early diagnosis of high risk patients and 
OPMD.
Discussion
- Chemiluminescence
Chemiluminescence involves emission of light from a 
chemical reaction between hydrogen peroxide and ace-
tylsalicylic acid inside a capsule light stick. This reac-
tion emits blue/white light (430-580 nm) whose princi-
ple is based on the reflective properties of tissues that 
present cellular alterations such as a higher nuclear/cy-
toplasmatic rate. The acetowhite lesion is more defined, 
whereas the normal tissue is dark. Chemiluminescence 
was first applied for the detection of dysplasia in the cer-
vix. The test has recently been adapted and proposed for 
oral mucosal examination based on the hypothesis that 
oral mucosal tissues may exhibit features similar to the 
cervical epithelium when subjected to chemilumines-
cence (27). One of the components of chemiluminescent 
examination is acetic acid pre-rinse. It is mainly done to 
remove the debris and glycoprotein layer for enhanced 
penetration and reflection of light. But acetic acid is also 
known to cause cellular dehydration and protein coagu-
lation that reduces the transparency of the epithelium.
This could be one of the reasons for the aceto-white ap-
pearance of the white lesions (28).     
Various studies have been done in literature to evalu-
ate efficacy of Vizilite, some have shown conflicting 
results. Most have shown that chemiluminescence in-
creases the brightness and margins of oral mucosal 
white lesions and thus assist in identification of mucosal 
lesions not detected under Conventional visual exami-
nation (COE). Ram et al. found that ViziLite was 100 % 
 
Mc Namara K  
et al. 2012 (25) 
Cross sectional 
study 
130 patients (1 OSCC, 2 
dysplasia, 32 benign 
lesions) 
Selection criteria: 
Consecutive recruitment 
for routine dental care 
Role of VELscope in 
routine screening for 
potentially malignant 
oral mucosal lesions 
Not reported Not reported OPMD/OSCC 
FVL in 1 malignant and one 
dysplastic lesion 
Benign 
FVL in 47 either provisionally 
diagnosed as benign 
 
Conclusion 
VELscope has the potential for 
false negatives and has high false 
positive rates 
Rana et al. 2012 
(22) 
Cross sectional 
study 
123 patients (OPMD :37 
leukoplakia,74 lichen 
planus, 2 ulcers,2 
candida,8 others, 6 
dysplasia, 117 non 
dysplastic) 
Selection criteria: 
Patients with OPMD 
Clinical evaluation of 
an autofluorescence 
diagnostic device for 
oral cancer detection 
Dysplasia: 
100% 
Dysplasia: 
74% 
OSCC/Dysplasia 
VELscope showed FVL in all 6 
cases of dysplasia 
Benign 
37.4%of all leuko/erythoplakias 
and 81.08% of lichen planus 
lesions showed FVL. 
 
Conclusion: 
VELscope is likely to lead to 
overdiagnosis if used by a non 
specialist 
Babiuch et al. 
2012 (26) 
Pilot study 50 patients 
Selection criteria: 
Patients with OSCC and 
lip cancer 
Use of VELscope for 
detection of OPMD 
and cancers 
100% 12.5% Autofluorescence was not highly 
specific for dysplasias and 
cancers, as FVL was observed in 
7 (87.5%) of the benign oral 
lesions, leading to a low 
specificity of12.5%.. 
 
Conclusion: 
VELscope  was useful in 
confirming the presence of oral 
lesions, the device was unable to 
discriminate high – risk from low 
– risk lesions 
 
Hanken  H et al.  
2013 (20) 
Single blinded 
study 
120 patients 
Group I examined with 
conventional white light 
Group II examined with 
VELscope 
Selection criteria: 
Patients with OPMD 
Detection of oral 
premalignant lesion 
with 
autofluorescence 
based imaging 
system-VELscope TM 
22% 8.4% Conclusion: 
VELscope device is a simple, 
non-invasive test of the oral 
mucosa, which can help the 
experienced clinician to find oral 
precursor malignant lesions 
Table 2 Continue.  Summarizes clinical trials to evaluate the efficacy of autofluorescence imaging ( VELscope) in detecting oral 
cancer and oral potentially malignant disorders.
OSCC; Oral squamous cell carcinoma, OPMD; Oral Potentally Malignant Disorders, FVL; Fluorescent visualization loss, VELscope; 
Visual Enhanced Light scope.
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sensitive with a low specificity of 12.5 % for detection 
of OPMD and OSCC (10). Rajmohan et al. assessed oral 
mucosa in normal, precancer and cancer patients using 
ViziLite and it was found 77.8 % sensitive for detecting 
dysplasia and 90 % sensitive for detecting OSCC (16). 
In a study  by Awan et al., the majority of mucosal disor-
ders were positive (aceto-white) for chemiluminescence 
(75.4%). ViziLite was useful in enhancing the visibility 
and sharpness of majority of the oral leukoplakia, mak-
ing the clinically evident lesions more prominent and 
distinct from surrounding oral mucosa. Fifty percent 
erythroplakia lesions were ViziLite positive (17).                         
There are many limitations associated with the use of 
Vizilite: Examination needs a dark environment, high 
cost, no permanent record unless photographed,low spe-
cificity for dysplasia, contributing to high referral rate 
and over-treatment, unable to detect some red lesions, 
acetic acid pre-rinse increases salivary flow that inter-
feres with mucosal surface reflectance, inability to objec-
tively measure the visualization results. This visualiza-
tion adjunct gives information only about the horizontal 
extent of the lesion (one dimension). The depth of the le-
sion which is more important in predicting the malignant 
behavior cannot be assessed through this modality (11).
Various studies proved that Vizilite is not a reliable tool 
to detect early premalignancy. In a study by Awan et al. 
majority of leukoplakias (80.3%) showed acetowhiten-
ing in contrast to only half of the erythroplakias. This 
clearly demonstrates the ability of the ViziLite to detect 
leukoplakias (white patches) more accurately and also 
indicates the inability of ViziLite to detect or enhance 
some red patches (erythroplakias). The ability of the 
ViziLite to detect dysplastic lesions has been greatly 
undermined by failure of the device to distinguish dys-
plastic from non-dysplastic lesions (sensitivity - 77.3%, 
specificity - 27.8%) (17). Mehrotra et al. found that 
Vizilite  was not sensitive (0%) in detecting dysplasia 
and OSCC and has no benefit in detecting OSCC and 
OPMD (14). Ujaoney et al. used chemiluminescence 
and Toulidine Blue for detecting of high risk oral pre-
cancerous lesions and Toulidine blue was found to be 
better diagnostic test than chemiluminesecence (15).
- Tissue autofluorescence
The autofluorescence of tissue and its potential use in 
cancer detection were described first in 1924. It is a 
phenomenon where by an extrinsic light source is used 
to excite endogenous fluorophores such as certain ami-
no acids, metabolic products, and structural proteins. 
Within the oral mucosa, the most relevant fluorophores 
are nicotinamide adenine dinucleotide (NADH) and fla-
vin adenine dinucleotide (FAD) in the epithelium and 
collagen cross-links in the stroma. The fluorophores 
absorb photons from the exogenous light source and 
emit lower energy photons which present clinically as 
fluorescence (23).  Each fluorophore is associated with 
specific excitation and emission wavelengths. When ir-
radiated with wavelengths between 375 and 440 nm,the 
fluorochromes show fluorescence in the green spectral 
range and normal, unaltered mucosa emits a pale green 
autofluorescence when viewed through a selective, nar-
rowband filter. A proper filtration is crucial, due to the 
intense light used for excitation of the fluorochromes. 
Without a proper filtration, it would be impossible to 
visualize the pale and narrow autofluorescence signal. 
However, dysplastic tissues lose fluorescence emission 
power due to a disruption in the distribution of the fluor-
ochromes and appear darker in colour in comparison to 
the surrounding healthy tissue (29).
A number of methods based on the principles of tissue 
fluorescence have been described for use in the oral 
cavity, including exogenous fluorescence, autofluores-
cent spectroscopy and autofluorescent imaging. Both 
exogenous fluorescence and autofluorescent spectrosco-
py due to practical purposes are unlikely to be applied 
as screening aids. In exogenous fluorescence, there is a 
delay before the fluorophore reaches an adequate con-
centration and the fluorophore also causes temporary 
photosensitisation to the subject, which may be deemed 
unacceptable to the individual. In autofluorescence 
spectroscopy, small optical fibres are used to expose the 
oral mucosa to different wavelengths of light and it is 
not possible to screen the entire oral cavity, therefore 
limiting its application. For these reasons, this review 
will focus on the use of autofluorescent imaging.
VELscope utilises blue light excitation between 400 
and 460 nm wavelength to enhance oral mucosal abnor-
malities by direct tissue autofluorescence. At these ex-
citation wavelengths, normal oral mucosa is associated 
with a pale green fluorescence when viewed through a 
filter, whereas abnormal tissue is associated with a loss 
of autofluorescence and appears dark. Neoplastic tis-
sues are expected to cause fluorescent visualisation loss 
(FVL) and thus appear as a dark area (30).
Several studies have investigated the effectiveness of 
the VELscope system as an adjunct to visual exami-
nation for 1) improving the distinction between nor-
mal and abnormal tissues (both benign and malignant 
changes) 2) differentiating between benign and dysplas-
tic/malignant changes 3) and identifying dysplastic/ma-
lignant lesions that are visible to naked eye under white 
light. Whether it can distinguish between dysplasia and 
benign inflammatory lesions is questioned. Benign in-
flammatory conditions can result in an increased blood 
supply to a lesion. The increased haemoglobin content 
(chromophores) may absorb light and cause FVL mim-
icking neoplasia (24,25).
Hanken H et al. examined 120 patients with suspicious 
oral lesions and found VELscope has a higher sensitiv-
ity (22.0%), and a lower specificity (8.4%). Also it is 
more promising than COE in detecting precursor oral 
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malignant lesions (20). Koch et al. in his study  showed 
a higher sensitivity (97%) and specificity of (95.8%) of 
VELscope to diagnose OSCC. The positive predictive 
value (PPV) was calculated was 41% and negative pre-
dictive value (NPV) was 75-80% (21).  Rana et al. in his 
study showed that using the VELscope leads to higher 
sensitivity (100% vs. 17%), but a lower specificity (74% 
vs. 97%) as  compared to COE. The major lack of the 
study was the large number of false-positive test results 
(22). In another study McNamara et al. concluded that 
COE is more valid than autofluorescence examination 
with VELscope in routine screening for OPMD (25). 
They believed that careful, systematic visual and tactile 
examination of the entire oral cavity on a regular basis 
remains the gold standard for early detection of OPMD. 
Babiuch et al.  found in his study that autofluorescence 
was not highly specific for dysplasias and cancers, as 
FVL was observed in 7 (87.5%) of the benign oral le-
sions, leading to low specificity of 12.5 %. But this de-
vice was unable to discriminate high risk from low risk 
lesions (26).
Conclusions
Detection of OPMDs before they advance to OSCC is 
necessary to improve survival rates for oral cancer. Evi-
dence indicates that COE is a poor discriminator of oral 
mucosal lesions, and this has led to the development of 
several adjunctive visualisation aids. Both devices are 
simple, non-invasive tests of the oral mucosa, which 
can help the experienced clinician to find oral precur-
sor malignant lesions and the correct location for taking 
biopsies within the altered mucosa. But in the literature, 
both techniques have limited ability to discriminate the 
high-risk lesions and have limitations which limit their 
use. In any case, conventional visual inspection under 
normal incandescent light, followed by biopsy of sus-
picious lesions, will remain the gold standard for the 
immediate future. Future approaches to optical imag-
ing could involve real time quantitative evaluation to 
determine a diagnosis for oral mucosal lesions rather 
than simply highlighting the presence of abnormalities, 
thus, making the possibility of “optical biopsy” a clini-
cal reality.
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